Michael Scolaro

Michael Scolaro

Sep 20, 2017

Group 6 Copy 394
0
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

How do chemical exposures trigger autoimmune diseases?

The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

Human placentophagy: What is the microbial composition of raw and processed placental tissue?

Placentophagy is gaining in popularity as supporters of this behavior claim it has the ability to improve...

Developing a New Mouse Model for Studying Chemotherapeutic Nephrotoxicity

A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to...

Backer Badge Funded